Alexion Pharmaceuticals

Biotechnology company; focuses on drugs treating thrombosis and hematological malignancies

Based in CA

🤖

AI Overview

With $355K in lobbying spend across 13 quarterly filings, Alexion Pharmaceuticals is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2022.

$355K
Total Spend
4
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$10K
2020$150K
2021$195K
2022$0

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Alexion Pharmaceuticals disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues

New Technology Add-on Payment (NTAP) for Medicare; Reimbursement issues related to coding (J code and C code)

Discussed CMS reimbursement and New Technology Add-on Payment(NTAP) for prescription drugs.

Medicare Policy and Reimbursement

S.4010 - Creating Hope Reauthorization Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.